HomeCompareMGRM vs O

MGRM vs O: Dividend Comparison 2026

MGRM yields 33.33% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGRM wins by $125.9K in total portfolio value
10 years
MGRM
MGRM
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full MGRM calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — MGRM vs O

📍 MGRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGRMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGRM + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGRM pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGRM
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, MGRM beats the other by $15,385.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGRM + O for your $10,000?

MGRM: 50%O: 50%
100% O50/50100% MGRM
Portfolio after 10yr
$97.2K
Annual income
$14,153.13/yr
Blended yield
14.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

MGRM
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$5.40
-10.0% upside vs current
Range: $5.40 — $5.40
Altman Z
12.6
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGRM buys
0
O buys
0
No recent congressional trades found for MGRM or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGRMO
Forward yield33.33%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$160.1K$34.2K
Annual income after 10y$23,203.52$5,102.74
Total dividends collected$113.6K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$5.40$64.00

Year-by-year: MGRM vs O ($10,000, DRIP)

YearMGRM PortfolioMGRM Income/yrO PortfolioO Income/yrGap
1← crossover$14,033$3,333.33$10,818$608.16+$3.2KMGRM
2$19,387$4,371.75$11,787$741.68+$7.6KMGRM
3$26,389$5,644.57$12,946$911.00+$13.4KMGRM
4$35,417$7,180.46$14,345$1,127.94+$21.1KMGRM
5$46,902$9,006.44$16,056$1,409.05+$30.8KMGRM
6$61,333$11,146.93$18,171$1,777.83+$43.2KMGRM
7$79,249$13,622.82$20,820$2,268.21+$58.4KMGRM
8$101,247$16,450.69$24,188$2,929.90+$77.1KMGRM
9$127,976$19,642.17$28,533$3,837.11+$99.4KMGRM
10$160,138$23,203.52$34,235$5,102.74+$125.9KMGRM

MGRM vs O: Complete Analysis 2026

MGRMStock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Full MGRM Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this MGRM vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGRM vs SCHDMGRM vs JEPIMGRM vs KOMGRM vs MAINMGRM vs STAGMGRM vs ADCMGRM vs NNNMGRM vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.